Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - BAKER JULIAN
Last Updated 
6-Oct-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

BAKER JULIAN: Declared Holdings
Company/RelationshipReportedShares  Ownership
Synageva BioPharma Corp.
Director
NasdaqGS:GEVA
(historical quotes, profile, other insiders)
6-Mar-148,172,521  Indirect
Idera Pharmaceuticals, Inc.
Director
NasdaqCM:IDRA
(historical quotes, profile, other insiders)
1-Oct-141,421,519  Indirect
Incyte Corporation
Director
NasdaqGS:INCY
(historical quotes, profile, SEC, other insiders)
21-May-1412,465,783  Indirect
XOMA Corporation
Director
NasdaqGM:XOMA
(historical quotes, profile, SEC, other insiders)
29-Oct-1217,888,512  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
1-Oct-14 *26,742IDRA Acquisition (Non Open Market) at $2.16 per share.
(Value of $57,762)
1-Jul-14 *18,546IDRA Acquisition (Non Open Market) at $2.83 per share.
(Value of $52,485)
21-May-14 *30,000INCY Option Exercise at $7.02 per share.
(Cost of $210,600)
10-Mar-14 *1,406,423IDRA Statement of Ownership
6-Mar-14 *375,000GEVA Purchase at $105.75 per share.
(Cost of $39,656,250)
25-Sep-13 *1,050,000GEVA Purchase at $56.63 per share.
(Cost of $59,461,500)
11-Jun-13 *30,000INCY Option Exercise at $4.44 per share.
(Cost of $133,200)
4-Jan-13 *859,720GEVA Purchase at $47.53 per share.
(Cost of $40,862,491)
29-Oct-12 *4,722,666XOMA Purchase at $3 per share.
(Cost of $14,167,998)

 

    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?